Biomarkers of COVID-19 and technologies to combat SARS-CoV-2
Autor
Zhang, Luoping
Guo, Helen
Institución
Resumen
Due to the unprecedented public health crisis caused by COVID-19, our first contribution to the newly
launching journal, Advances in Biomarker Sciences and Technology, has abruptly diverted to focus on
the current pandemic. As the number of new COVID-19 cases and deaths continue to rise steadily
around the world, the common goal of healthcare providers, scientists, and government officials
worldwide has been to identify the best way to detect the novel coronavirus, named SARS-CoV-2, and to
treat the viral infection – COVID-19. Accurate detection, timely diagnosis, effective treatment, and future
prevention are the vital keys to management of COVID-19 and can help curb the viral spread.
Traditionally, biomarkers play a pivotal role in the early detection of disease etiology, diagnosis,
treatment and prognosis. To assist myriad ongoing investigations and innovations, we developed this
current article that overviews known and emerging biomarkers for SARS-CoV-2 detection, COVID-19
diagnostics, treatment and prognosis, and ongoing work to identify and develop more biomarkers for new
drugs and vaccines. Moreover, biomarkers of socio-psychological stress, the high-technology quest for
new virtual drug screening, and digital applications are described.